{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:14:45Z","timestamp":1778706885737,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-110-2314-B-002-031"],"award-info":[{"award-number":["MOST-110-2314-B-002-031"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-002-062-MY3"],"award-info":[{"award-number":["108-2314-B-002-062-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.xphs.2022.09.023","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T01:20:51Z","timestamp":1664068851000},"page":"740-750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Formulation Development of Doxycycline-Loaded Lipid Nanocarriers using Microfluidics by QbD Approach"],"prefix":"10.1016","volume":"112","author":[{"given":"Chia Ying","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ting","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuimin","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7204-4681","authenticated-orcid":false,"given":"Chien-Ming","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Yu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8011-2317","authenticated-orcid":false,"given":"Jeng-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7439-8774","authenticated-orcid":false,"given":"Chin-Tin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.xphs.2022.09.023_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1248\/bpb.b16-00624","article-title":"Liposomal delivery systems: design optimization and current applications","volume":"40","author":"Abu Lila","year":"2017","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"10.1016\/j.xphs.2022.09.023_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051611","article-title":"Dexamethasone loaded liposomes by thin-film hydration and microfluidic procedures: formulation challenges","volume":"21","author":"Al-Amin","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.xphs.2022.09.023_bib0003","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3041969","article-title":"Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer","volume":"2021","author":"Allahou","year":"2021","journal-title":"Int J Biomater"},{"issue":"15","key":"10.1016\/j.xphs.2022.09.023_bib0004","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1039\/c3sm52879k","article-title":"Ultrasonic energy in liposomes production: process modelling and size calculation","volume":"10","author":"Barba","year":"2014","journal-title":"Soft Matter"},{"issue":"3","key":"10.1016\/j.xphs.2022.09.023_bib0005","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0021-9258(18)70226-3","article-title":"Phosphorus assay in column chromatography","volume":"234","author":"Bartlett","year":"1959","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xphs.2022.09.023_bib0006","series-title":"Design of Experiments for Pharmaceutical Product Development)","article-title":"Box\u2013Behnken designs and their applications in pharmaceutical product development","author":"Beg","year":"2021"},{"issue":"1","key":"10.1016\/j.xphs.2022.09.023_bib0007","first-page":"13","article-title":"Liposomal oxytetracycline and doxycycline: studies on enhancement of encapsulation efficiency","volume":"3","author":"Budai","year":"2009","journal-title":"Drug Discov Ther"},{"issue":"2","key":"10.1016\/j.xphs.2022.09.023_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2022.09.023_bib0009","first-page":"1719","article-title":"A tale of the two PEGylated liposomal doxorubicins","volume":"8","author":"Chou","year":"2015","journal-title":"Oncotarg Ther"},{"issue":"3","key":"10.1016\/j.xphs.2022.09.023_bib0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08982104.2017.1343836","article-title":"The significance of drug-to-lipid ratio to the development of optimized liposomal formulation","volume":"28","author":"Chountoulesi","year":"2018","journal-title":"J Liposomes Res"},{"key":"10.1016\/j.xphs.2022.09.023_bib0011","first-page":"2411","article-title":"Synergetic effects of doxycycline-loaded chitosan nanoparticles for improving drug delivery and efficacy","volume":"7","author":"Cover","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"10.1016\/j.xphs.2022.09.023_bib0012","first-page":"12","article-title":"Double optimization of rivastigmine-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery using the quality by design (QbD) approach: formulation variables and instrumental parameters","author":"Cunha","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.xphs.2022.09.023_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.xphs.2022.09.023_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12090863","article-title":"Encapsulation of nedaplatin in Novel PEGylated liposomes increases its cytotoxicity and genotoxicity against A549 and U2OS human cancer cells","volume":"12","author":"El-Shafie","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.xphs.2022.09.023_bib0015","series-title":"Guidance for industry. Q8 Pharmaceutical Development","year":"2006"},{"key":"10.1016\/j.xphs.2022.09.023_bib0016","series-title":"Guidance for Industry: Q9 Quality Risk Management","author":"Food","year":"2006"},{"issue":"6","key":"10.1016\/j.xphs.2022.09.023_bib0017","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.mcg.0000129058.69524.90","article-title":"Mid-esophageal ulceration and candidiasis-associated distal esophagitis as two distinct clinical patterns of tetracycline or doxycycline-induced esophageal injury","volume":"38","author":"Gencosmanoglu","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.xphs.2022.09.023_bib0018","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4605-1","article-title":"Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience","volume":"18","author":"Glassman","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xphs.2022.09.023_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposomes composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.xphs.2022.09.023_bib0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/08982109509010233","article-title":"Mechanisms of liposomes formation","volume":"5","author":"Lasic","year":"1995","journal-title":"J Liposomes Res"},{"key":"10.1016\/j.xphs.2022.09.023_bib0021","article-title":"Sustainable technologies for liposomes preparation","volume":"165","author":"Leitgeb","year":"2020","journal-title":"J Supercrit Fluids"},{"issue":"1","key":"10.1016\/j.xphs.2022.09.023_bib0022","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0005-2736(94)90038-8","article-title":"Effect of liposomes size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes","volume":"1190","author":"Litzinger","year":"1994","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.xphs.2022.09.023_bib0023","first-page":"11","article-title":"Surface response based modeling of liposomes characteristics in a periodic disturbance mixer","author":"Lopez","year":"2020","journal-title":"Micromachines"},{"issue":"1-2","key":"10.1016\/j.xphs.2022.09.023_bib0024","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0005-2736(98)00125-4","article-title":"Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study","volume":"1374","author":"Maurer","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.xphs.2022.09.023_bib0025","first-page":"11","article-title":"Solvothermal synthesis combined with design of experiments-optimization approach for magnetite nanocrystal clusters","author":"Medinger","year":"2021","journal-title":"Nanomaterials"},{"issue":"4","key":"10.1016\/j.xphs.2022.09.023_bib0026","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/milmed\/165.4.316","article-title":"Doxycycline-induced esophageal ulceration in the U.S. Military service","volume":"165","author":"Morris","year":"2000","journal-title":"Mil Med"},{"issue":"11","key":"10.1016\/j.xphs.2022.09.023_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11110610","article-title":"Development of injectable pegylated liposomes encapsulating disulfiram for colorectal cancer treatment","volume":"11","author":"Najlah","year":"2019","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.xphs.2022.09.023_bib0028","first-page":"12","article-title":"A proposed methodology for a risk assessment-based liposomes development process","author":"Nemeth","year":"2020","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.xphs.2022.09.023_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23040907","article-title":"Liposomal drug delivery systems and anticancer drugs","volume":"23","author":"Olusanya","year":"2018","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.xphs.2022.09.023_bib0030","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrd2591","article-title":"Strategies in the design of nanoparticles for therapeutic applications","volume":"9","author":"Petros","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.xphs.2022.09.023_bib0031","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030610","article-title":"Effect of membrane surface modification using chitosan hydrochloride and lactoferrin on the properties of astaxanthin-loaded liposomes","volume":"25","author":"Qiang","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.xphs.2022.09.023_bib0032","first-page":"13","article-title":"Rifampicin-liposomes for mycobacterium abscessus infection treatment: intracellular uptake and antibacterial activity evaluation","author":"Rinaldi","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.xphs.2022.09.023_bib0033","first-page":"12","article-title":"Manufacturing considerations for the development of lipid nanoparticles using microfluidics","author":"Roces","year":"2020","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.xphs.2022.09.023_bib0034","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1099\/00222615-48-7-689","article-title":"In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline","volume":"48","author":"Sangare","year":"1999","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.xphs.2022.09.023_bib0035","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s13346-018-0587-4","article-title":"Rapid optimization of liposomes characteristics using a combined microfluidics and design-of-experiment approach","volume":"9","author":"Sedighi","year":"2019","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.xphs.2022.09.023_bib0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2020.07.002","article-title":"Liposomes: advancements and innovation in the manufacturing process","volume":"154-155","author":"Shah","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2022.09.023_bib0037","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.bb.09.060180.002343","article-title":"Comparative properties and methods of preparation of lipid vesicles (liposomes)","volume":"9","author":"Szoka","year":"1980","journal-title":"Annu Rev Biophys Bioeng"},{"issue":"7101","key":"10.1016\/j.xphs.2022.09.023_bib0038","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","author":"Whitesides","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.xphs.2022.09.023_bib0039","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-008-9667-3","article-title":"Pharmaceutical quality by design: Product and process development, understanding, and control","volume":"25","author":"Yu","year":"2008","journal-title":"Pharm Res"},{"issue":"4","key":"10.1016\/j.xphs.2022.09.023_bib0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"Aaps J"},{"issue":"20","key":"10.1016\/j.xphs.2022.09.023_bib0041","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1039\/b003565n","article-title":"Effect of temperature, pressure and lipid acyl chain length on the structure and phase behaviour of phospholipid-gramicidin bilayers","volume":"2","author":"Zein","year":"2000","journal-title":"Phys Chem Chem Phys"},{"issue":"7","key":"10.1016\/j.xphs.2022.09.023_bib0042","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1021\/la204833h","article-title":"Bottom-up design and synthesis of limit size lipid nanoparticle systems with aqueous and triglyceride cores using millisecond microfluidic mixing","volume":"28","author":"Zhigaltsev","year":"2012","journal-title":"Langmuir"},{"issue":"6","key":"10.1016\/j.xphs.2022.09.023_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/mi10060414","article-title":"Evaluating nanoparticles in preclinical research using microfluidic systems","volume":"10","author":"Zhu","year":"2019","journal-title":"Micromachines"},{"issue":"1","key":"10.1016\/j.xphs.2022.09.023_bib0044","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2009.05.036","article-title":"Liposomes drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties","volume":"139","author":"Zucker","year":"2009","journal-title":"J Controlled Release"},{"key":"10.1016\/j.xphs.2022.09.023_bib45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2006.08.044","article-title":"Multivariate toxicity screening of liposomal formulations on a human buccal cell line","volume":"330","author":"Smistad","year":"2007","journal-title":"Int J Pharm"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922004257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354922004257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:55:43Z","timestamp":1778705743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354922004257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0022354922004257"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2022.09.023","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Formulation Development of Doxycycline-Loaded Lipid Nanocarriers using Microfluidics by QbD Approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2022.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}